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In the current study, we are investigating eﬀect of reﬁned QKL on ischemia-reperfusion-induced brain injury in mice. Methods.
Mice were employed to induce ischemia-reperfusion injury of brain by middle cerebral artery occlusion (MCAO). RQKL solution
was administered with diﬀerent doses (0, 1.5, 3, and 6mL/kg body weight) at the same time of onset of ischemia, and with the dose
of 1.5mL/kg at diﬀerent time points (0, 1.5, 3, 6, and 9h after MCAO). Neurological function and brain infarction were examined
and cell apoptosis and ROS at prefrontal cortex were evaluated 24h after MCAO, and western blot and intracellular calcium were
also researched, respectively. Results. RQKL of all doses can improve neurological function and decrease brain infarction, and
it performed signiﬁcant eﬀect in 0, 1.5, 3, and 6h groups. Moreover, RQKL was able to reduce apoptotic process by reduction of
caspase-3expression,orrestraintofeIF2aphosphorylationandcaspase-12activation.ItwasalsoabletoreduceROSandmodulate
intracellular calcium in the brain. Conclusion. RQKL can prevent ischemic-induced brain injury with a time window of 6 h, and
its mechanism might be related to suppress ER stress-mediated apoptotic signaling.
1.Introduction
Ischemic stroke is a life-threatening disease featured by
high morbidity and mortality. Investigating new drugs is a
hotspot and the diﬃculty of ischemic stroke research. The
committee ofthe StrokeTherapy AcademicIndustry Round-
table proposed that studies of drugs for brain ischemia
should pay attention to their pharmaceutical window [1, 2].
In clinical practice, treatment for stroke patients is always
delayed after onset, and the time at which treatment is
administered is highly correlated with therapeutic eﬀect.
Qingkailing (QKL) injection was originally prepared by
the Beijing University of Chinese Medicine in the 1970s, by
modifying a traditional Chinese medicine, Angongniuhuang
pills, composed of Radix isatidis, Flos Lonicerae, Concha
Margaritifera Usta, baicalin, Fructus gardeniae, cholic acid,
hyodeoxycholic acid, and Cornu Bubali [3]. It has been
extensively used to treat the acute stages of cerebrovascular
disease and has performed excellently in improving neuro-
logical function [4]. Animal experiments have shown that
QKL injection can promote endothelial nitric oxide syn-
thase expression, reduce calcium overload, regulate matrix
metallopeptidase 9 expression, and inhibit inﬂammation in
the murine model of cerebral ischemia/reperfusion [5–8].
However, QKL is confronted with handicaps from drug
safety regulations in recent years, which has severely embar-
rassed its clinical application [9]. QKL being composed
of complex components is the central problem of quality
stabilization and clinic safety. Based on this, we developed
reﬁned Qingkailing (RQKL), aimed at acute ischemic stroke.
Reﬁned Qingkailing (RQKL) injection consists of
cholic acid, hyodeoxycholic acid, baicalin, and jasminoidin
(Figure 1). Baicalin is derived from the dried root of
Scutellaria baicalensis Georgi which is named as Huang Qin
in traditional Chinese medicine (TCM), and jasminoidin is
derived from the dried fruit of Gardenia jasminoides Ellis
which is named as Zhi Zi in TCM. Both herbs provide
excellent antioxidative and anti-inﬂammation eﬀects [10–
13]. Cholic acid and hyodeoxycholic acid are both bile acids
and have neuron-protective eﬀects [14, 15]. Furthermore,2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Molecular structure of the four components of RQKL.
the combination of the four components can signiﬁcantly
improve their eﬀectiveness [16].
The endoplasmic reticulum (ER) regulates protein syn-
thesis, protein folding and traﬃcking, cellular responses to
stress, and intracellular calcium levels [17]. The conditions
that impair the function of the ER, designated “ER stress”,
can lead to an accumulation of unfolded proteins in the
ER lumen [18]. However, if ER stress is too severe, the
unfolded protein response ultimately initiates an apoptotic
pathway [19]. ER stress-induced cell death has been shown
toinvolvetheactivationofcaspase-12[20,21],whileanother
component of the ER stress-mediated apoptotic pathway is
elf-2a [22]. Several studies have shown that cerebralischemia
is a pathological ER stressor, which can trigger the shutdown
of protein translation and apoptosis, suggesting that ER
plays an important role in cerebral ischemia [23, 24]. Thus,
reducing ER stress may provide a therapeutic way to block
the pathological process induced by cerebral ischemia [18,
24].
This paper is designed to explain the dose eﬀect and
therapeutic time window of RQKL on MCAO rodents, as
well as to elaborate intervention eﬀect of RQKL on neuron
apoptosis due to ER stress after cerebral ischemia.
2.MaterialsandMethods
2.1. Animals. We used 154 healthy, male, Kunming mice
weighing 25–28g, and 90 healthy, male, C57BL/6 mice
weighing 25–30g, purchased from Vital River Laboratories,
Beijing, China (no. SCXK (Beijing) 2006-0009) and housed
in the Central Laboratory, Beijing University of Chinese
Medicine on a 12h light: dark cycle at 25 ± 1◦C, with relative
humidity of 40–60% and automatic day-night rhythm, the
mice had free access to standard lab chow and tap water.Evidence-Based Complementary and Alternative Medicine 3
Procedures involving animals and their care were conducted
in compliance with institutional guidelines in accordance
withNIHGuidefortheCareandUseofLaboratoryAnimals,
NIH publication no. 85-23, 1985.
2.2. Drugs. QKL injection, composed of cholic acid, Concha
Margaritifera Usta (powder), hyodeoxycholic acid, Fructus
Gardeniae, Cornu Bubali (powder), Radix Isatidis, baicalin,
and Flos Lonicerae [25], was purchased from the Pharma-
ceutical Factory of Beijing University of Chinese Medicine
(no. 813204A). RQKL injection composed of cholic acid,
hyodeoxycholic acid, baicalin, and jasminoidin (Figure 1).
Proportion and concentration of 4 compositions is consis-
tent with QKL injection. RQKL injection is provided by Prof.
ShouyingDu,aﬃliatedtoSchoolofChineseMateriaMedica,
Beijing University of Chinese Medicine.
2.3. MCAO Model Establishment. Mice were anesthetized
with 4% chloral hydrate (350mg/kg) and kept under heating
lamp to maintain the core body temperature at 36.5±0.5◦C.
Under a dissecting microscope (SXE-1, Shanghai Precision
Instrument, Shanghai, China), the right common carotid
artery, internal carotid artery, and external carotid artery
were carefully exposed, and the external carotid artery was
coagulated distal to the bifurcation. A 0.16mm diameter
nylon ﬁlament (tip diameter 0.20±0.01mm; Beijing Sunbio
Biotech, Beijing, China) was inserted through the external
c a r o t i da r t e r ys t u m pa n dg e n t l ya d v a n c e d1 0m mt oo c c l u d e
the origin of the middle cerebral artery [26, 27]. The body
temperature of the animals was maintained at 37◦C. The
ﬁlament was removed after 1.5h. Postoperatively, the mice
were housed separately. Neurological function was evaluated
when the mice were awake [28]; those with scores less than 2
were excluded.
2.4. Grouping of Experimental Animals and RQKL Injection.
In the dose-eﬀect experiments, high, moderate, low dose
RQKL injection and QKL injection and model groups were
injected with 6, 3, 1.5mL/kg RQKL and 3mL/kg QKL or
equal volume of normal saline, respectively, via the tail veins
[7]. Both injections were diluted in saline with diﬀerent
concentrationsandtheﬁnaldoseinjectedtoeachanimalwas
9mL/kg.Theﬁrstinjectionwasperformedimmediatelyafter
model establishment, followed by administration after 4h,
and once every 12h thereafter.
For time window experiments, the model group was
injected with normal saline, and each RQKL group with
RQKL (3mL/kg) diluted using normal saline, via the tail
vein.Inmodel and0hgroupsmice,wereﬁrstinjectedsimul-
taneouslywiththemiddlecerebralartery,wasoccluding.The
other groups received RQKL injections at 1.5, 3, 6, 9h after
MCAO, followed by a second injection after 4h, and every
12h thereafter [29], Figure 3(A).
2.5. Assessment of Neurological Function after Focal Cerebral
Ischemia/Reperfusion Using Clark Scores. Mice neurological
function was evaluated using a blind method 24h after
model establishment. Clark scores [28] include focal and
general neurological function, which reﬂect ischemia foci-
induced neurological function injury and general function,
respectively.Thefocalneurologicalfunctionwasscoredfrom
0–28, and the general function ranged from 0–32. Normal
mice had a score of 0. High scores reﬂect severe neurological
functional injury.
2.6. Infarct Volume Assessment. Following neurological func-
tion evaluation, mice were sacriﬁced, and the brain was
harvested for TTC staining (Nanjing Greensynthesis Bio-
chemical Co., Ltd., Nanjing, Jiangsu, China). The percent
of infarct volume out of the entire brain represented the
degree of cerebral infarction. Serial coronal sections (1mm
thickness) were prepared and soaked in 2% TTC phosphate
buﬀer at 37◦C for 10 minutes in the dark. Normal brain
tissueswerestainedred,whileinfarcttissueswerenotstained
(white). The sections were soaked in 4% paraformaldehyde
phosphate buﬀe rf o r3 0m i n u t e s ,a r r a n g e di no r d e ra n d
scanned (Tsinghua Unisplendour A688, Xi’an, China). Areas
of red and white staining were measured using a computer
color multimedia image analysis system (Image-Pro Plus6.0,
Media Cybernetics, Wyoming, USA). The percent of infarc-
tion is given by the equation: %Infarct volume = Infarct
volume/Total volume of slice × 100 [30, 31].
2.7. TUNEL Staining. After 24h of recovery, the animals
were euthanatized and the brain was rapidly removed,
frozen, and cut into 20μm slices. Terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL) staining was
performed using a kit for programmed cell death (In
Situ Cell Death Detection Kit, TMR Red, Roche, USA)
according to the manufacturer’s directions [32]. Sections of
prefrontal cortex were collected. Five areas of each section
were examined by ﬂuorescence microscope (ZEISS, LSM510
meta, Germany) in the prefrontal cortex of the ischemic
hemisphere and TUNEL-positive cells were quantiﬁed [18].
2.8. Measurement of ROS Generation. Brain reactive oxygen
species (ROS) production was determined using dihy-
droethidium (DHE) microﬂuorography [33]. DHE is a
cell permeable dye, which can be oxidized into ethid-
ium and other products by superoxide [33, 34]. Animals
were sacriﬁced at 24h after MCAO, and the brains were
removed, frozen, and sectioned (20μm thickness) on a
cryostat. Sections of prefrontal cortex were collected. A ROS
ﬂuorescence detection kit (Genmed, Wyoming, USA) was
used. DHE solution was superfused on the brain sections
for 60 minutes and ﬂuorescence intensity was detected by
ﬂuorescence microscopy (ZEISS, LSM510 meta, Germany).
Theﬂuorescenceintensitiesofﬁvediﬀerentﬁeldsofthebrain
section were averaged and expressed as relative ﬂuorescence
units (RFU) [35].
2.9. Western Blot. Mice were sacriﬁced after 24h of cere-
bral ischemia, the forehead cortex was collected and
homogenated in an ice bath. Proteins were separated on
sodium dodecyl sulfate polyacrylamide gel electropheresis
and transferred to a nitrocellulose membrane. Blots were4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀe c to fd i ﬀerent doses of RQKL on infarction volume and neurological function of MCAO mouse. Five brain coronal sections,
2mm thick, were selected for tetrazolium chloride staining. The infarct volume was quantiﬁed as a percentage of total volume, with large
infarcts representing more severe injury. The percent of infarct volume was signiﬁcantly less in RQKL injection groups compared with
model group (a). RQKL injection at diﬀerent doses signiﬁcantly improve focal and general neurological function (b, c). The scores of focal
neurological function and general neurological function were 0 in normal mice. High scores represent severe injury. ΔΔP<0.01, versus
model group, #P < 0.05, ##P < 0.01, versus model group. Data are expressed as mean ± SEM, n = 10.
b l o c k e dw i t h5 %n o n f a td r ym i l ki np h o s p h a t eb u ﬀered
saline, pH 7.6, with 0.1% Tween-20 buﬀer and then
incubated with antiphospho-eIF2α (Ser51) polyclonal anti-
body (Cell Signaling Technology Inc., Tokyo, Japan), anti-
caspase12 polyclonal antibody (Cell Signaling Technology
Inc., Tokyo, Japan), or anti-caspase3 (8G10) polyclonal
antibody (Cell Signaling Technology Inc., Tokyo, Japan),
subsequently incubated with secondary anti-rabbit antibody
conjugated with horseradish peroxidase. Finally, membranes
were processed for detection using the ECL system.
2.10. Intracellular Calcium Measurement. Intracellular cal-
cium concentration was measured by ﬂow cytometry using
Fluo-3AM ﬂuorescence as described previously [36, 37].
Mice were sacriﬁced 2h after middle cerebral artery occlu-
sion or 10h reperfusion after 2h of occlusion. Forehead
cortex and hippocampus were separated in ice bath and
prepared into cell suspension. Cell density was adjusted
with D-Hanks solution to about 1 × 106. Suspension was
incubated at 37 for 10 minutes, then 2μL/mL Fluo-3AM dye
working solution was added and mixed to uniform. Mixed
solution was incubated at 37◦C for 40 minutes in dark place.
Flow cytometry (FACS Calibur, Becton Dickinson, USA)
analysis was performed with excitation wavelength 488nm
and emission wavelength 528nm. The results are expressed
as mean ﬂuorescence intensity (MFI) [37, 38].
2.11. Statistical Analysis. Data were analyzed using SPSS 16.0
(SPSS, Chicago, IL, USA). One-way analysis of variance was
used followed by post hoc analysis for signiﬁcance with the
Student-Newman-Keuls multiple comparison test. All values
a r ee x p r e s s e da sm e a n± SEM. A value of P<0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Dose-Response of RQKL for Focal Cerebral
Ischemia/Reperfusion
3.1.1. Dose-Response Eﬀects on Infarct Volume. Mice with
focal cerebral ischemia/reperfusion were injected with diﬀer-
ent doses of RQKL. Infarct foci were evident in the brain of
mice at 24h after ischemia/reperfusion. Compared to model
group,theinfarctionsizewasreducedby49%,48%,55%and
37% (P<0.01) in QKL and high, moderate, and low dose
RQKL injection groups, respectively (Figure 2(a)).
3.1.2. Dose-Response Eﬀects on Neurological Function. Prior
to MCAO, scores of focal neurological function and general
neurological function were 0. Mice developed neurological
functional injury 24h after MCAO; however, QKL and all
doses of RQKL ameliorated this injury compared with theEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Eﬀects of RQKL injection at diﬀerent time points in mice undergoing middle cerebral artery occlusion. Flow chart of time
window experiment of RQKL (A). Cerebral infarct volume (B, C) and neurological function scores (D, E) were evaluated 24h after brain
ischemia. Five brain coronal sections, 2mm thick, were selected for tetrazolium chloride staining. Red stain represents normal tissues; white
representstheinfarctregion(B).Inpanels(D)and(E),highscoresrepresentseriousinjury.RQKLinjectionat0,1.5,3,or6hafterinfarction
signiﬁcantly reduced infarct volume and improved focal and general neurological function, but 9h group had no eﬀects. ΔΔP<0.01, versus
model group, #P < 0.05, ##P < 0.0 1 ,v e r s u sm o d e lg r o u p .D a t aa r ee x p r e s s e da sm e a n± SEM, the numbers of each group were 10, 11, 12, 9,
9, 12, 9, respectively.6 Evidence-Based Complementary and Alternative Medicine
model group (P<0.05 or P<0.01). The results are con-
sistent with our preliminary experiments [29]. The groups
receiving the moderate QKL and RQKL dose (3mL/kg)
exhibited the greatest improvement (P<0.01). Moderate
and high dose RQKL injection was able to restore focal
neurological function (P<0.01); however, the eﬀect of low
dose group was relatively poor (P<0.05), Figures 2(b) and
2(c).
3.2. The Therapeutic Time Window of RQKL
3.2.1. Cerebral Infarct Volume after Treatment with RQKL at
0, 1.5, 3, 6, 9h after Ischemia. In preliminary experiment,
we found that QKL had a wide therapeutic time window
[29]. In this study, RQKL also showed a broad time window.
Injection of 3mL/kg RQKL was most eﬀective at reducing
infarct volume and improving neurological function, so this
dose was used in time window experiments. RQKL injection
at 0, 1.5, 3, and 6h after ischemia signiﬁcantly reduced
cerebral infarct volume (P<0.01 or P<0.05). The largest
reduction of infarct volume (68%) was in the 0h group
compared with model group (P<0.01). Percent reduction
of infarct volume gradually decreased with increasing delay
before QKL injection (infarct size: 55%, 50%, 39% in the
1.5, 3, and 6h groups, resp.). However, 9h group reduced
cerebral infarct volume 18% than model group, but with no
signiﬁcance (P>0.05) (Figures 3(A) and 3(B)).
3.2.2.NeurologicalFunctionScoresafterTreatmentwithRQKL
at 0, 1.5, 3, 6, 9h after Ischemia. Consistent with dose-eﬀect
experiments, the general and focal neurological functions
were signiﬁcantly improved in the 0h group (P<0.01).
In other treatment groups, RQKL injected at 1.5, 3, and 6h
after MCAO signiﬁcantly enhanced both general and focal
neurological functions (P<0.01), but administration at
9hwasnoteﬀective. However, with the ﬁrst treating time
delay, the eﬀects gradually decreased. The focal neurological
functionof 6 and 9h groups were signiﬁcantly lower than 0h
group (P<0.05, P<0.01, resp.), while general neurological
function of 9h group was signiﬁcantly lower than 0h group
(P<0.05) (Figures 3(C) and 3(D)).
3.2.3. Eﬀects of RQKL on Neurons Apoptosis. Cellular apop-
tosis is an important mechanism of nerve injury after brain
ischemia/reperfusion [18]. The TUNEL method was used
to investigate whether an antiapoptotic eﬀect was involved
in the neuroprotection by RQKL. Few apoptotic cells were
observed in brain tissues of sham mice. A large number of
TUNEL-positive neurons were observed in the prefrontal
cortex 24h after ischemia. Following QKL (3mL/kg) or
RQKL (6, 3 and 1.5mL/kg) injections, the number of
TUNEL-positive neurons was reduced signiﬁcantly (Figures
4(a), 4(b), and 4(c)). This showed that RQKL reduced
the number of apoptotic cells in brains of MCAO mice.
Meanwhile,theantiapoptosiseﬀectofRQKLshoweddosede-
pendence.
3.2.4. Eﬀects of RQKL on Protein Level of Caspase-3, Pro-
Caspase12, and P-eIF2α. Caspase-3 is an important key
protein in cell apoptosis. Moreover, it is well known that
caspase-3 is induced after ischemic insults [39]. In this study,
caspase-3 in the cortex increased markedly, whereas QKL
and RQKL injections noticeably reduced the protein level
(Figures 5(a) and 5(b)). Caspase-12 plays a role in apoptotic
cell death by ER stress [20]. Therefore, we examined the
eﬀects of RQKL treatment on the induction of caspase-
12 after ischemia. Western blotting analysis showed that
caspase-12 was activated 24h after hypoxia-ischemia, as
evidenced by a decrease in the level of the procaspase-12,
which was largely restored by QKL and RQKL (about 50%
restoration compared with the model group) (Figures 5(a)
and 5(c)). A key feature of ER stress induced by cerebral
ischemia is the blocking of translation at the initiation
step, as indicated by increased phosphorylation of eIF2α
[40, 41]. Therefore, we examined whether RQKL aﬀects the
phosphorylation of eIF2α. The level of phospho-eIF2α in
injured cortex was markedly increased 24h after ischemia,
whereas the injection of QKL or RQKL noticeably reduced
the levels of phospho-eIF2α (approximately 30 to 60%
reduction, compared with the model group) (Figures 5(a)
and 5(d)).
3.2.5. Antioxidative Eﬀects of RQKL Injection. Reactive oxy-
gen species production was detected using DHE staining.
As shown in (Figures 6(A) and 6(B), no ﬂuorescence was
evident in sham mice brain. A large number of ﬂuorescent
nervecellscontributedtosigniﬁcantlyenhancedﬂuorescence
in the prefrontal cortex at 24h after MCAO. Following
treatment with QKL and RQKL, the number of ﬂuorescent
nerve cells was reduced, and the ﬂuorescence intensity was
weakened, indicating that RQKL reduced ROS production.
Quantitative analysis showed that ﬂuorescence in the cortex
was signiﬁcantly decreased in all the RQKL doses groups
comparedwiththemodelgroup(P<0.01,Figure 6(c)).This
was consistent with our previous work that QKL injection
has antioxidative eﬀects [29].
3.2.6. Intracellular Calcium. As shown in Figure 7, intracel-
lularCa2+ markedlyincreased2hafterischemia,signiﬁcantly
compared with the sham group (P<0.01), whereas the
injection of RQKL noticeably reduced the Ca2+ content.
However, for mice suﬀering 2h ischemia following 10h
reperfusion, only intracellular Ca2+ of hippocampal cells
increased, and RQKL did not signiﬁcantly reduce it. So
RQKL only performed modulation eﬀect of intracellular
calcium in the early period after ischemia.
4. Discussion
QKL injection is a famous Chinese medicine widely used
in China for more than thirty years. However, since the
National Accident Data Recorder Monitoring Center noticed
the ﬁrst case of anaphylaxis following administration of QKL
in November 2001, medical journals have published some
case reports about the adverse drug reactions and adverseEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Eﬀect of RQKL injection on cell apoptosis in prefrontal cortex of mice (TUNEL staining). After middle cerebral artery occlusion
for 24h, apoptotic cells were detected in the prefrontal cortex ((A), ×400). Apoptotic cells were labeled with red ﬂuorescence. (a) sham, (b)
ischemia, c-ischemia+QKL3ml/kg, d-ischemia+RQKL 6mL/kg, (e) ischemia+RQKL3ml/kg, (f) ischemia+RQKL1.5mL/kg. Five animals
were selected from each group; three sections were selected from each site; and ﬁve 400-fold ﬁelds of view were randomly selected from each
section to quantify the mean of positive cells. Results are expressed as mean ± SEM (B). ΔΔP<0.01, versus sham-surgery group; ##P < 0.01,
versus model group.8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Eﬀect of RQKL on protein levels of caspase3, procaspase12, and P-elF2a in cortex of MCAO mouse. Mice were subjected to 1.5h
ischemia followed 22.5h reperfusion. QKL or RQKL was injected immediately after ischemia. The tissue samples were from the cerebral
cortex. The panels are representative Western blotting analyses of caspase3, procaspase12 and P-elF2a. The gray values were calculated, and
protein levels were expressed by the ratio of aim protein/β-actin as mean ± SEM. Notes ΔΔP<0.01, versus normal, ##P < 0.01, versus
ischemia, #P < 0.05, versus ischemia, n = 5. Primary antibodies were diluted, caspase12 1:400, caspase3 1:2000, and P-elF2a 1:500.
events due to its use, so the safety of QKL injections became
a focus of public opinion [9]. Much more attention has
been attached to drug safety of traditional Chinese medicine
(TCM), as well as eﬃciency. Redeveloping famous Chinese
medicine formulas is a new way to improve traditional
Chinese medicine, which is important for the modernization
and globalization of TCM. Aimed at acute ischemic stroke,
one of the indications of QKL, we reﬁned QKL into a
novel medicine, namely RQKL. It is composed of only four
components of QKL, which has an advantage in quality
stabilization and drug safety. In this study, we researched
the eﬃciency and therapeutic time window of RQKL using
MCAO mice, compared with QKL. The results showed
that the injection of RQKL at doses of 1.5, 3, 6mL/kg
protected the brain from ischemic injury, as evidenced by
reductions in infarct volume and neurological function.
Most importantly, administration of RQKL provided a wide
therapeutic window of 6h.
The time window in which a drug is eﬀective varies
between drugs, commonly ranging between 2–4h for
ischemic stroke drugs [42–44], but occasionally extended to
12h [45]. Administration beyond the therapeutic window
can reduce or even abolish the pharmacodynamic action.
This present study has deﬁned the therapeutic window
for RQKL injection in the treatment of brain ischemia.
Incompatible with QKL, RQKL can also signiﬁcantly reduce
infarct volume and improved focal and general neurological
function when administered in a broad time window after
ischemia. RQKL injection at 6h after ischemia signiﬁcantly
reduced infarct volume and improved neurological function,
so the therapeutic window for RQKL injection for MCAO
mice can be said to extend to over 6h. This may be proﬁted
from multimechanisms of the compound Chinese medicine,
for it showed remarkable eﬀects of promoting endothelial
nitric oxide synthase expression, reducing calcium over-
load, regulating matrix metallopeptidase 9 expression and
inhibiting inﬂammation in a murine model of cerebral
ischemia/reperfusion [5–8].
In this study, we found that RQKL can eﬀectively
suppress apoptosis in vivo. RQKL treatment signiﬁcantly
inhibited apoptosis under in vivo ischemic conditions, as
indicated by the results of TUNEL assays. Moreover, the
present ﬁndings indicated that the protective eﬀect of RQKL
on ischemic injury may be medicated in part by restoration
of ER dysfunction. Previous studies showed that mitochon-
dria play a central role in neurons apoptosis after ischemia.
However,recentstudiessuggestedthatERdamageisinvolved
in neuronal cell death induced by cerebral ischemia [23,
24, 46]. In the present study, we investigated the eﬀect of
RQKL on ER dysfunction under pathological conditions.
Consistent with the results reported in recent years [18, 47],
in mice subjected to 1.5h ischemia and 22.5h reperfusion,
we observed an remarkable increase in the level of the eIF2α-
phosphorylation in the ischemic cortex, which indicated
that ischemia/reperfusion caused severe ER damage. On the
other hand, treatment with RQKL signiﬁcantly inhibited p-
eIF2α induction. Therefore, the protective eﬀects of RQKL in
ischemia/reperfusion injury may be partly due to inhibition
of ER stress and subsequent apoptotic signaling pathway.Evidence-Based Complementary and Alternative Medicine 9
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Figure 6: Eﬀects of RQKL injection on reactive oxidative species in mice undergoing middle cerebral artery occlusion. Relative intensity of
red ﬂuorescence represents reactive oxygen species (ROS) content in the prefrontal cortex ((A) ×200) regions of the injured hemisphere.
(a) sham, (b) ischemia, (c) ischemia+QKL3ml/kg, (d) ischemia+RQKL 6mL/kg, e-ischemia+RQKL3ml/kg, (f) ischemia+RQKL1.5mL/kg.
Relative ﬂuorescence intensity in ﬁve sites from one section was determined by ﬂuorescence microscopy. The mean value of ROS content
was calculated and expressed as mean ± SEM (B). ΔΔP<0.01, versus sham, ##P < 0.01, versus ischemia, n = 5.10 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Eﬀect of RQKL on intracellular Ca2+ in brain cells. Mice
were divided into ﬁve groups: sham group, I2h group for cerebral
ischemia 2h, I2hR10h group suﬀering ischemia 2h followed 10h
reperfusion. RQKL therapeutic group received RQKL (3mL/kg)
immediately after ischemia. Neurons of hippocampal and forehead
c o rt e xr e g i o n sw e r ed e t e c t e db yﬂ o wc yt o m e t rya n a l y s i s .T h er e s u l t s
are expressed as mean ﬂuorescence intensity (MFI). Note. ΔΔP<
0.01, versus sham, ΔP<0.05, versus sham, ##P < 0.01, versus
ischemia, n = 6.
ER stress-induced cell death has been shown to involve
the activation of caspase-12, which subsequently activates
executer caspases such as caspase-3 [20, 21, 48, 49]. Caspase-
12 is speciﬁc to insults that elicit ER stress and is not
proteolyticallyactivatedbyotherdeathstimuli[20].Previous
studies have shown that caspase-12 is activated after per-
manent and transient middle cerebral artery occlusion, and
many caspase-12 positive cells exhibited DNA fragmenta-
tion; on the other hand, mice that are deﬁcient in caspase-12
are more resistant to ER stress-induced apoptosis [20]. This
indicatedtheactivationofcaspase-12isinvolvedinischemia-
induced apoptosis. We found caspase-12 was activated
24h after MCAO and RQKL remarkably suppressed the
activation, which indicated that RQKL inhibits caspase-
12 dependent apoptotic pathway. Furthermore, RQKL also
decreased caspase-3 level signiﬁcantly. Caspase-3 activation
is involved in caspase-12 mediated apoptotic cascade, while
activated caspase-3 is directly responsible for DNA fragmen-
tation [20, 21, 48]. It is possible that caspase-3 activation
is inhibited by suppression of caspase-12. Thus, RQKL
might inhibit caspase-3 activation by suppressing ER stress-
mediated apoptotic signaling and therefore reduce the extent
of apoptosis.
Studies suggested that multiple causes of ER stress occur
in neurons following cerebral I/R: intracellular calcium ho-
meostasis, aggregation of proteins, decreased protein degra-
dation, and accumulation of ROS in ER and Golgi struc-
tures [50, 51]. Recent studies suggested that disruption of
intracellular calcium homeostasis could induce ER stress and
kill cells [52]. In this study, we found intracellular calcium
raised markedly 2h after ischemia; on the other hand, RQKL
can signiﬁcantly depress intracellular Ca2+. Like intracellular
calcium homeostasis, ROS also played an important eﬀect
in causing ER stress [51, 53]. RQKL showed excellent
antioxidative eﬀects, evidenced by notably reducing ROS. So
the inhibition eﬀe c tt oE Rs t r e s so fR Q K Lm a yb ei m m e d i a t e
or mediated by anti-oxidative as well as intracellular calcium
modulation. Considering the ﬁndings of the present study,
we speculate that RQKL is a promising novel drug for acute
ischemia stroke, and it has multiple neuroprotective eﬀects,
although the mechanism of its actions needs to be elucidated
further.
Abbreviations
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